Showing 13–24 of 174 results

  • Atacand Plus 16\12.5mg 14 Tablets

    Atacand Plus 16\12.5mg 14 Tablets

    0 out of 5
    EGP116

    Atacand Plus 16/12.5 mg (14 Tablets) Active Ingredients: Candesartan cilexetil 16 mg (Angiotensin II receptor blocker – ARB) Hydrochlorothiazide 12.5 mg (Thiazide diuretic) Therapeutic Class:Antihypertensive combination (ARB + diuretic) Indications: Treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not adequately controlled by monotherapy with candesartan or hydrochlorothiazide alone. May be…

  • Atacand Plus 32\25mg 14 Tablets

    Atacand Plus 32\25mg 14 Tablets

    0 out of 5
    EGP179

    Atacand Plus 32/25 mg (14 Tablets) Active Ingredients: Candesartan cilexetil 32 mg (Angiotensin II receptor blocker – ARB) Hydrochlorothiazide 25 mg (Thiazide diuretic) Therapeutic Class:Antihypertensive combination (ARB + diuretic) Indications: Treatment of essential hypertension in patients whose blood pressure is not adequately controlled by candesartan or hydrochlorothiazide alone. May be used as part of a…

  • Ateno 100mg 20 Tablets

    Ateno 100mg 20 Tablets

    0 out of 5
    EGP26

    Ateno 100 mg (20 Tablets) Active Ingredient: Atenolol 100 mg – Beta-1 selective adrenergic blocker Therapeutic Class:Beta-blocker – Antihypertensive and antianginal agent Indications: Hypertension (high blood pressure) Angina pectoris (chest pain due to reduced blood flow to the heart) Arrhythmias (irregular heartbeats) Post-myocardial infarction management (to reduce risk of further cardiac events) Dosage: Usual adult…

  • Ateno 50mg 20 Tablets

    Ateno 50mg 20 Tablets

    0 out of 5
    EGP20

    Ateno 50 mg (20 Tablets) Active Ingredient: Atenolol 50 mg – Beta-1 selective adrenergic blocker Therapeutic Class:Beta-blocker – Antihypertensive and antianginal agent Indications: Hypertension (high blood pressure) Angina pectoris (chest pain due to reduced blood flow to the heart) Arrhythmias (abnormal heart rhythms) Prevention of recurrent heart attacks after myocardial infarction Dosage: Usual adult dose:…

  • Avivavasc 10\160 mg 28 Tablets

    Avivavasc 10\160 mg 28 Tablets

    0 out of 5
    EGP140

    Avivavasc 10/160 mg (28 Tablets) Active Ingredients: Amlodipine 10 mg – Calcium channel blocker Valsartan 160 mg – Angiotensin II receptor blocker (ARB) Therapeutic Class:Combination antihypertensive (Calcium channel blocker + ARB) Indications: Essential hypertension (for patients whose blood pressure is not adequately controlled by monotherapy) May be used as replacement therapy for patients already stabilized…

  • Avivavasc 5\160 mg 28 Tablets

    Avivavasc 5\160 mg 28 Tablets

    0 out of 5
    EGP124

    Avivavasc 5/160 mg (28 Tablets) Active Ingredients: Amlodipine 5 mg – Calcium channel blocker Valsartan 160 mg – Angiotensin II receptor blocker (ARB) Therapeutic Class:Combination antihypertensive (Calcium channel blocker + ARB) Indications: Essential hypertension (to lower high blood pressure) Used when blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan alone Dosage:…

  • Bisocard 10mg 30Tablets

    Bisocard 10mg 30Tablets

    0 out of 5
    EGP84

    Bisocard 10 mg (30 Tablets) Active Ingredient: Bisoprolol 10 mg Therapeutic Class:Beta‑blocker – Cardioselective Indications: Hypertension (high blood pressure) Chronic stable angina (chest pain) Chronic heart failure (as part of standard therapy for selected patients) Used after myocardial infarction to improve survival in stable patients. Dosage: Usual adult dose: 1 tablet once daily, preferably in…

  • Bisocard 2.5mg 30Tablets

    Bisocard 2.5mg 30Tablets

    0 out of 5
    EGP51

    Bisocard 2.5 mg (30 Tablets) Active Ingredient: Bisoprolol 2.5 mg Therapeutic Class:Beta‑blocker – Cardioselective Indications: Hypertension (high blood pressure) Chronic stable angina (chest pain) Chronic heart failure (as part of standard therapy for selected patients) May also be used after myocardial infarction to improve survival in stable patients. Dosage: Usual adult dose: 1 tablet once…

  • Bisocard 5mg 30Tablets

    Bisocard 5mg 30Tablets

    0 out of 5
    EGP63

    Bisocard 5 mg (30 Tablets) Active Ingredient: Bisoprolol 5 mg Therapeutic Class:Beta‑blocker – Cardioselective Indications: Hypertension (high blood pressure) Chronic stable angina (chest pain) Chronic heart failure (as part of standard therapy for selected patients) May also be used after myocardial infarction to improve survival in stable patients. Dosage: Usual adult dose: 1 tablet once…

  • Bisocard Plus 5\12.5mg 30Tablets

    Bisocard Plus 5\12.5mg 30Tablets

    0 out of 5
    EGP63

    Bisocard Plus 5/12.5 mg (30 Tablets) Active Ingredients: Bisoprolol 5 mg (Beta‑blocker, cardioselective) Hydrochlorothiazide 12.5 mg (Thiazide diuretic) Therapeutic Class:Combination antihypertensive – Beta-blocker + Thiazide diuretic Indications: Essential hypertension (high blood pressure) in adults, especially when monotherapy with either agent is insufficient. May be used in patients requiring both heart rate control and fluid balance…

  • Blokatens 10\160mg 28 Tablets

    Blokatens 10\160mg 28 Tablets

    0 out of 5
    EGP160

    Blokatens 10/160 mg (28 Tablets) Active Ingredients: Amlodipine 10 mg (Calcium channel blocker) Telmisartan 160 mg (Angiotensin II receptor blocker, ARB) Therapeutic Class:Combination antihypertensive – Calcium channel blocker + ARB Indications: Essential hypertension (high blood pressure) in adults, particularly when monotherapy with either agent is insufficient. May help reduce cardiovascular risk in patients requiring dual…

  • Blokatens 5\160mg 28 Tablets

    Blokatens 5\160mg 28 Tablets

    0 out of 5
    EGP150

    Blokatens 5/160 mg (28 Tablets) Active Ingredients: Amlodipine 5 mg (Calcium channel blocker) Telmisartan 160 mg (Angiotensin II receptor blocker, ARB) Therapeutic Class:Combination antihypertensive – Calcium channel blocker + ARB Indications: Essential hypertension (high blood pressure) in adults, especially for patients not adequately controlled with monotherapy. Helps reduce cardiovascular risk in patients requiring dual therapy….

End of content

End of content